相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cellular Uptake of Psychostimulants - Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?
Ole Jensen et al.
FRONTIERS IN PHARMACOLOGY (2021)
Role of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones
L. Duart-Castells et al.
NEUROPHARMACOLOGY (2021)
Drug-Drug Interactions at Organic Cation Transporter 1
Shiwei Zhou et al.
FRONTIERS IN PHARMACOLOGY (2021)
Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro
Marco Niello et al.
FRONTIERS IN PHARMACOLOGY (2021)
α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters
Julian Maier et al.
NEUROPHARMACOLOGY (2021)
Organic Cation Transporters in Health and Disease
Hermann Koepsell
PHARMACOLOGICAL REVIEWS (2020)
Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic Strategy
Marco Niello et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison ofIn VitroMethods to Assess the Potency of Drugs That Target Monoamine Transporters
Marija Ilic et al.
FRONTIERS IN PHARMACOLOGY (2020)
Polytox synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux
Felix P. Mayer et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
para-Trifluoromethyl-methcathinone is an allosteric modulator of the serotonin transporter
Marco Niello et al.
NEUROPHARMACOLOGY (2019)
Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter
Rheaclare Fraser-Spears et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Rat Organic Cation Transporter 1 Contains Three Binding Sites for Substrate 1-Methyl-4-phenylpyridinium per Monomer
Thorsten Keller et al.
MOLECULAR PHARMACOLOGY (2019)
Affinity of Ketamine to Clinically Relevant Transporters
Markus Keiser et al.
MOLECULAR PHARMACEUTICS (2018)
The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease
Sanjay K. Nigam
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates
Philip J. Sandoval et al.
MOLECULAR PHARMACOLOGY (2018)
Pharmacological profile of mephedrone analogs and related new psychoactive substances
Dino Luethi et al.
NEUROPHARMACOLOGY (2018)
The psychostimulant (±)-cis-4,4′-dimethylaminorex (4,4′-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters
Julian Maier et al.
NEUROPHARMACOLOGY (2018)
An unsuspected role for organic cation transporter 3 in the actions of amphetamine
Felix P. Mayer et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol
Edith Pascale Mofo Mato et al.
SYSTEMATIC REVIEWS (2018)
Interaction and Transport of Methamphetamine and its Primary Metabolites by Organic Cation and Multidrug and Toxin Extrusion Transporters
David J. Wagner et al.
DRUG METABOLISM AND DISPOSITION (2017)
Diazepam Inhibits Electrically Evoked and Tonic Dopamine Release in the Nucleus Accumbens and Reverses the Effect of Amphetamine
Alexander Gomez-A et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release
Amy J. Eshleman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition
J. Wang
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Role of Hum an Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions
Cristina Arimany-Nardi et al.
FRONTIERS IN PHARMACOLOGY (2016)
Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approachs
Henry C. Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Role of organic cation transporters (OCTs) in the brain
Thomas Courousse et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Amphetamines, new psychoactive drugs and the monoamine transporter cycle
Harald H. Sitte et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3
Vivian Massmann et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
PharmGKB summary: very important pharmacogene information for SLC22A1
Srijib Goswami et al.
PHARMACOGENETICS AND GENOMICS (2014)
Revisiting Serotonin Reuptake Inhibitors and the Therapeutic Potential of Uptake-2 in Psychiatric Disorders
Lynette C. Daws et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration
Mladen V. Tzvetkov et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Polyamine Transport by the Polyspecific Organic Cation Transporters OCT1, OCT2, and OCT3
Monica Sala-Rabanal et al.
MOLECULAR PHARMACEUTICS (2013)
Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3
Britta Haenisch et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2012)
Genetically Polymorphic OCT1: Another Piece in the Puzzle of the Variable Pharmacokinetics and Pharmacodynamics of the Opioidergic Drug Tramadol
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Interaction of organic cation transporter 3 (SLC22A3) and amphetamine
Hao-Jie Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics
Britta Haenisch et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2010)
Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin
Ying Chen et al.
PHARMACOGENETICS AND GENOMICS (2009)
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1
Gustav Ahlin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice
Vincent Vialou et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications
Hermann Koepsell et al.
PHARMACEUTICAL RESEARCH (2007)
Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain
Mingyan Zhou et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro
Bertha K. Madras et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain
Anne Amphoux et al.
NEUROPHARMACOLOGY (2006)
Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease
C Popp et al.
MOLECULAR PHARMACOLOGY (2005)
Subtype-specific affinity for corticosterone of rat organic cation transporters rOCT1 and rOCT2 depends on three amino acids within the substrate binding region
V Gorboulev et al.
MOLECULAR PHARMACOLOGY (2005)
Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors
MI Damaj et al.
MOLECULAR PHARMACOLOGY (2004)
Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3)
JW Jonker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations
JW Jonker et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3
M Hayer-Zillgen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
分享论文
